Chemical name: (6R-trans)-6-(1,3-benzodioxol-5-yl)- 2,3,6,7,12,12a-hexahydro-2-methyl-pyrazino [1′, 2′
Formula: C22H19N3O4
Anabolic activity index: not a steroid
Androgenic activity index: not a steroid

TADACIP-20

1. Active Substance:

• Tadalafil: Tadalafil is the active pharmaceutical ingredient in Tadacip-20 tablets. It belongs to a class of medications called phosphodiesterase type 5 (PDE5) inhibitors. Tadalafil works by inhibiting the enzyme PDE5, which regulates blood flow to the penis. By inhibiting PDE5, tadalafil increases blood flow to the penis during sexual stimulation, resulting in improved erectile function.

2. Indications:

• Erectile Dysfunction (ED): Tadacip-20 is indicated for the treatment of erectile dysfunction in adult men. Erectile dysfunction, also known as impotence, is the inability to achieve or maintain a penile erection sufficient for satisfactory sexual performance.
• Pulmonary Arterial Hypertension (PAH): In addition to treating erectile dysfunction, tadalafil is also approved for the treatment of pulmonary arterial hypertension (PAH), a condition characterized by high blood pressure in the arteries of the lungs.

3. Dosage:

• Each Tadacip-20 tablet contains 20 mg of tadalafil.
• The recommended dosage for the treatment of erectile dysfunction is usually 10 mg or 20 mg taken orally as needed, prior to anticipated sexual activity.
• For the treatment of pulmonary arterial hypertension, the dosage may vary depending on the severity of the condition and the individual patient’s response to therapy.

4. Administration:

• Tadacip-20 tablets are taken orally with a full glass of water.
• The tablets can be taken with or without food.
• It is important to take Tadacip-20 approximately 30 minutes to 1 hour before anticipated sexual activity for optimal efficacy.

5. Effectiveness:

• Tadacip-20 has been shown to be effective in improving erectile function in men with erectile dysfunction, with effects lasting up to 36 hours.
• In patients with pulmonary arterial hypertension, tadalafil helps to relax the blood vessels in the lungs, reducing pulmonary blood pressure and improving exercise capacity.

6. Safety Profile:

• Tadacip-20 is generally well-tolerated when used as prescribed. Common side effects may include headache, flushing, indigestion, back pain, muscle aches, and nasal congestion.
• Serious side effects such as priapism (prolonged erection), sudden vision loss, and hearing loss are rare but possible.
• Patients should be monitored for signs of adverse reactions, especially when initiating treatment or adjusting dosage.

7. Contraindications:

• Tadacip-20 is contraindicated in patients with known hypersensitivity to tadalafil or any of the excipients in the formulation.
• It should not be used in patients who are taking nitrates or guanylate cyclase stimulators, as co-administration may lead to severe hypotension.

8. Precautions:

• Tadacip-20 should be used with caution in patients with a history of cardiovascular disease, liver or kidney impairment, bleeding disorders, or anatomical deformation of the penis.
• It should be avoided in patients with a recent history of stroke or heart attack.

9. Storage:

• Tadacip-20 should be stored at room temperature (15°C to 30°C) in a dry place, away from moisture and heat.
• Keep the medication out of reach of children and pets.

Tadacip-20 tablets, manufactured by Cipla, offer a reliable and convenient treatment option for men with erectile dysfunction. Treatment should be initiated and monitored by a qualified healthcare professional, and patients should be informed about potential side effects and precautions associated with the use of tadalafil.